Which of the following is a marker for neural tube defects?
First, the core concept. Neural tube defects are congenital malformations like spina bifida or anencephaly. The marker here is AFP, which is a fetal protein produced by the liver and yolk sac. Elevated maternal serum AFP levels are a key indicator. I should explain the mechanism: when the neural tube doesn't close, AFP leaks into amniotic fluid and then into maternal blood.
Next, why the correct answer is right. AFP is a glycoprotein, and in open neural tube defects, the defect in the spinal or cranial area allows AFP to escape into the amniotic fluid. This leads to higher levels in maternal serum during the second trimester. It's important to note that AFP testing is part of the maternal serum screening, often combined with other markers like acetylcholinesterase in amniotic fluid.
For the wrong options, I need to think of common distractors. Maybe hCG, inhibin A, or estriol. Each of these are part of other screens. For example, hCG is elevated in Down syndrome, inhibin A in trisomy 18, and estriol in Turner syndrome. Explain why each isn't specific to neural tube defects.
Clinical pearl: Remember that AFP is also a tumor marker for hepatocellular carcinoma and germ cell tumors, but in prenatal context, it's crucial for neural tube defects. Also, the timing of the test (15-20 weeks) is key.
Finally, the correct answer line. Need to make sure the answer is labeled correctly. Let me check the character count to stay within limits. Avoid markdown except for bold labels. Use precise terms like "alpha-fetoprotein (AFP)" and "maternal serum AFP levels."
**Core Concept**
Neural tube defects (NTDs) like spina bifida and anencephaly are associated with elevated levels of **alpha-fetoprotein (AFP)** in maternal serum and amniotic fluid. AFP is a fetal glycoprotein produced by the yolk sac and liver, and its leakage into amniotic fluid occurs due to open NTDs, leading to increased maternal serum concentrations.
**Why the Correct Answer is Right**
Elevated maternal serum **alpha-fetoprotein (AFP)** is the primary biochemical marker for open neural tube defects. In NTDs, the defective neural tube allows AFP to escape into the amniotic cavity and subsequently into maternal circulation. AFP levels peak at 15β20 weeks of gestation, making this the optimal window for screening. Confirmatory testing includes amniocentesis, where AFP and acetylcholinesterase levels are measured to distinguish NTDs from other causes of elevated AFP (e.g., fetal abdominal wall defects).
**Why Each Wrong Option is Incorrect**
**Option A:** Human chorionic gonadotropin (hCG) is elevated in Down syndrome, not NTDs.
**Option B:** Inhibin A is associated with trisomy 18 and elevated in maternal serum screening for Down syndrome.